Ribavirin to Prevent RSV Pneumonia in Bone Marrow Transplant Patients

NCT00031473 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

90

Enrollment

NIH

Sponsor class

Conditions

Respiratory Syncytial Virus Infections

Interventions

DRUG: Virazole (Ribavirin) Inhalation Solution

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)